Chart Industries (GTLS) 8-K Regulation FD Disclosure

Chart Industries, Inc.

Investment Highlights

August 2010

Exhibit 99.1

Disclosure

Forward-Looking

Statements:

This

presentation

includes

“forward-looking

statements”

within

the

meaning

of

the

Private

Securities

Litigation

Reform

Act

of

1995.

The

use

of

words

such

as

“may”,

“might”,

“should”,

“will”,

“expect”,

“plan”,

“anticipate”,

“believe”,

“estimate”,

“project”,

“forecast”,

“outlook”,

“intend”,

“future”,

“potential”

or

“continue”,

and

other

similar

expressions

are

intended

to

identify

forward-looking

statements.

All

of

these

forward-looking

statements

are

based

on

estimates

and

assumptions

by

our

management

as

of

the

date

of

this

presentation

that,

although

we

believe

to

be

reasonable,

are

inherently

uncertain.

Forward-looking

statements

involve

risks

and

uncertainties

that

could

cause

the

Company’s

actual

results

or

circumstances

to

differ

materially

from

those

expressed

or

implied

by

forward-looking

statements.

These

risks

and

uncertainties

include,

among

others,

the

following:

the

cyclicality

of

the

markets

that

the

Company

serves

and

the

vulnerability

of

those

markets

to

economic

downturns;

the

negative

impacts

of

the

recent

global

economic

and

financial

crisis;

a

delay,

significant

reduction

in

or

loss

of

purchases

by

large

customers;

fluctuations

in

energy

prices;

competition;

our

reliance

on

key

suppliers

and

potential

supplier

failures

or

defects;

the

modification

or

cancellation

of

orders

in

our

backlog;

the

impact

of

the

financial

distress

of

third

parties;

changes

in

government

healthcare

regulations

and

reimbursement

policies;

general

economic,

political,

business

and

market

risks

associated

with

the

Company's

global

operations;

fluctuations

in

foreign

currency

exchange

and

interest

rates;

potential

future

charges

to

income

associated

with

potential

impairment

of

the

Company’s

significant

goodwill

and

other

intangibles;

the

Company's

ability

to

successfully

manage

its

costs,

core

business

resources

and

growth,

including

its

ability

to

successfully

acquire

and

integrate

new

product

lines

or

businesses

and

manage

operational

expansions;

the

loss

of

key

employees

and

deterioration

of

labor

and

employee

relations;

the

pricing

and

availability

of

raw

materials;

the

Company's

ability

to

manage

its

fixed-price

contract

exposure;

the

regulation

of

our

products

by

the

U.S.

Food

&

Drug

Administration

and

other

governmental

authorities;

additional

liabilities

related

to

taxes;

the

costs

of

compliance

with

environmental,

health

and

safety

laws,

and

potential

liabilities

under

these

laws;

the

impact

of

hurricanes

and

other

severe

weather;

litigation

and

disputes

involving

the

Company,

including

product

liability,

contract,

warranty,

pension,

intellectual

property

and

employment

claims;

volatility

and

fluctuation

in

the

price

of

the

Company’s

stock;

and

risks

associated

with

our

indebtedness.

For

a

discussion

of

these

and

additional

risks

that

could

cause

actual

results

to

differ

from

those

described

in

the

forward-looking

statements,

see

disclosure

under

Item

1A.

“Risk

Factors”

in

the

Company’s

most

recent

Annual

Report

on

Form

10-K

and

other

recent

filings

with

the

Securities

and

Exchange

Commission,

which

should

be

reviewed

carefully.

Please

consider

the

Company’s

forward-looking

statements

in

light

of

these

risks.

Any

forward-looking

statement

speaks

only

as

of

its

date.

We

undertake

no

obligation

to

publicly

update

or

revise

any

forward-looking

statement,

whether

as

a

result

of

new

information,

future

events

or

otherwise,

except

as

required

by

law.

1

2

Energy industry is the largest end-user of the Company’s products

#1 or #2 in all primary markets served

Global operations with 12 manufacturing facilities and about 2,500 employees

$592 million of sales,$94 million of operating income

in 2009

Company Overview

Chart Industries is a leading provider of highly engineered cryogenic

equipment for the hydrocarbon, industrial gas, and biomedical markets.

Asia

23%

U.S.

41%

Americas

(Non-US)

6%

RoW

12%

Europe

18%

2009 Sales by Segment

Energy

63%

BioMedical

15%

General

Industrial

22%

2009 Sales by Region

2009 Sales by End-User

Energy &

Chemicals

43%

Distribution

& Storage

42%

BioMedical

15%

E&C Segment Overview

3

Heat Exchanger

Cold Box

Production

Heat

Exchangers

68%

Cold Boxes and

LNG VIP

32%

2009 Sales by Product/Region

Highlights

Leading provider of heat exchangers and cold boxes critical

to LNG, Olefin petrochemicals and natural gas processing

markets

–

Separation, liquefaction and purification of hydrocarbon and

industrial gases

Leading market positions domestically and internationally

One of three global suppliers of mission-critical LNG and

LNG liquefaction equipment

Selected Products

Americas

(Non-US)

5%

RoW

20%

Asia

38%

U.S.

36%

Europe

1%

D&S Segment Overview

4

2009 Sales by Product/Region

Highlights

46%

of 2009 segment sales derived from products used in

energy applications

Manufacturing strategically located near growing end

markets and lower-cost countries

–

Positioned to capitalize on strong expected growth in Asia and

Eastern Europe

–

Continued investment in key global manufacturing facilities

Bulk

MicroBulk

Distribution

Storage

Selected Products

Satellite

LNG Storage

Bulk Storage

Systems

46%

Packaged Gas

Systems

22%

VIP, Systems

and Components

6%

Parts, Repair and On-

Site Service

11%

Beverage Liquid

CO

Systems

8%

LNG Terminals

and Vehicle Fuel

Systems 7%

Americas

(Non-US)

7%

RoW

5%

Asia

13%

U.S.

49%

Europe

26%

2

BioMedical

Segment Overview

5

2009 Sales by Product/Region

Highlights

Strong expected growth in oxygen respiratory therapy and

biomedical research, led by international markets

End markets include:

–

Home healthcare and nursing home

–

Hospitals and long-term care

–

Biomedical and pharmaceutical research

–

Animal breeding

Portable Oxygen

Lab Storage

Stainless Steel Freezer

End-Use Consumption

Respiratory

Therapy

Systems

46%

Other

5%

Biological

Storage

Systems

49%

Selected Products

Americas

(Non-US)

9%

U.S.  

34%

Europe

47%

Asia

10%

Summary of Investment Highlights

End markets are positioned to recover with strong energy demand

–

Energy demand recently forecasted to expand 40% between now and 2030*

–

Global investment of $26 trillion, over $1 trillion/year, is needed to keep up with demand*

A market leader

–

Leading market position in all segments

–

Strong balance sheet with significant liquidity

Aggressive response to the economic downturn

–

Cost management made a priority along with operations excellence

–

Flexible cost structure provides the ability to quickly downsize

SG&A and plant overhead costs

–

Have emerged more strongly positioned

Continued growth initiatives

–

Six acquisitions completed since 2006

–

Expect continued strategic, accretive acquisition activity

–

New product development taking advantage of leading proprietary technology and designs

Strong track record of maximizing operating efficiencies and growth

–

14% sales compound annual growth rate (“CAGR”) 2004 through 2009

–

21% operating income CAGR 2004 through 2009

6

*

Source:

International

Energy

Agency

-

World

Energy

Outlook

2009,

Reference

Scenario.

Based

on

assumption

that

governments

do

not

change

their

policies

relating

to

energy;

differences

would

arise

should

governments

change

energy

policies

7

World primary demand for natural gas expands on average by 1.5% per year.  The biggest increases occur in

the

Middle

East,

China

and

India.

New

power

generation

stations

absorb

45%

of

the

increase.

*

“Global

gas

demand

is

likely

to

rise

by

25%,

while

the

use

of

LNG

is

set

to

surge

by

40%

by

2020.”

Source:

ExxonMobil

quoted

at

CWC

World

LNG

Summit,

Barcelona

-

(12/2/2009)

$220 billion annual investment into the entire gas-supply infrastructure is needed through 2030 *

“China’s

LNG

demand

forecast

for

2020

raised

by

48%.”

Source:

Wood

Mackenzie

Consultants

Ltd.

–

(7/26/2010)

* Source:

International

Energy

Agency

–

World

Energy

Outlook

2009, Reference Scenario

Reference Scenario based on assumption that governments do

not change their policies relating to energy; differences would

arise should governments change energy policies

Energy Trends

World Primary Energy Demand by Fuel*

8

Natural gas is increasing its penetration as a viable transportation fuel due to its high

energy density, lower costs, and low emissions

Chart

provides

products

/

solutions

for

the

full

LNG

value

chain

from

LNG

terminal

equipment

/ liquefiers to on-board fuel tanks

Technical and proprietary innovation with numerous patents granted in our LNG products

Energy Trends

Growth Initiatives

9

Current economic environment continues to provide acquisition opportunities for Chart

with its strong balance sheet and more than adequate liquidity

Chart’s acquisition criteria

–

Global niche engineered equipment, systems or aftermarket business

–

Fit with Chart value proposition including product/technology synergies

–

#1 or potential to become #1 within existing or adjacent growth markets

–

Geographic expansion or cost savings synergies

Completed six acquisitions since 2006

–

Cooler Service – air cooled heat exchangers –  2006

–

Flow Instruments – flow meter systems –  2008

–

Tri-Thermal – heat exchanger aftermarket parts –  2009

–

Golden Phoenix – biological storage containers –  2009

–

Covidien – liquid oxygen therapy systems –  2009

–

Cryotech International – cryogenic injectors, vacuum insulated piping systems/manifolds and

liquid cylinder repair -  2010

Global Manufacturing and Distribution Platform

10

Operating leverage provides the flexibility to expand and reduce

capacity

as needed with minimal capital expenditures

Manufacturing facilities are strategically located in lower-cost countries and

near centers of demand

Total:

Manufacturing:

Europe

Asia-Pacific

12

8

4

2

3

2

North America

Corporate

Energy & Chemicals

Distribution & Storage

BioMedical

Strong Track Record of Successful Execution

11

Drivers of Growth

Energy & Chemicals

–

Significant exposure to expected global

energy demand growth

–

Environmental legislation and alternative

energy opportunities

Distribution & Storage

–

Expanding aftermarket business

–

Global relationships with major industrial gas

companies

–

Well positioned in areas of expected growth

–

Alternative fuel opportunities with LNG

BioMedical

–

Liquid oxygen growth in emerging markets

–

Increasing biological research expenditures

–

Aging demographic

CAGR

(2004-2009)

Sales   14%

Oper. Inc.  21%

CAGR

(2004-2009)

Sales   14%

Oper. Inc.  21%

(1)   Included in 2005 are non-recurring costs of $26.5 million for the acquisition of Chart Industries

by First Reserve.

(1)

0

20

40

60

80

100

120

140

160

0

100

200

300

400

500

600

700

800

2004

2005

2006

2007

2008

2009

Sales

Operating Income

12

2010 Outlook

We

continue

to

see

an

improving

global

market

in

all

of

our

business

segments

including

more

quote

opportunities

and

orders

The

Company

successfully

completed

a

new

$200

million

senior

secured

credit

facility

during

the

2

nd

quarter.

The

refinancing

extends

maturity

profile,

improves

liquidity

and

maintains

modest

total

and

net

leverage

First

and

second

quarter

financial

results

were

in

line

with

our

expectations

and

within

the

analysts’

forecasted

ranges

after

excluding

restructuring

costs,

etc.

We

reaffirmed

our

outlook

for

the

year

with

net

sales

of

$530

to

$560

million

and

earnings

of

$0.40

to

$0.60

per

diluted

share.

Our

EPS

range

includes

$0.20

of

restructuring

and

acquisition

costs,

and

the

write-off

of

non-cash

deferred

financing

costs

as

a

result

of

our

debt

refinancing.

Therefore,

our

adjusted

EPS

would

be

$0.60

to

$0.80

per

share

excluding

these

costs.

Positioned on Strong and Stable Platform for Growth

Flexible Manufacturing Platform

–

Ability to ramp up or scale back production as demand fluctuates

–

Necessary capacity expansion/contraction is easily attainable

–

Proven ability to implement cost-savings measures during periods of sharp decline

Very strong balance sheet

–

Significant improvement in net debt position

–

Substantial free cash flow growth

–

Continued ability to invest in and take advantage of growth opportunities

Stable business model

–

Attractive industry with long-term customer relationships

–

Solid platform with worldwide presence and leading market positions in all segments

Positioned for continued significant growth as markets recover

–

Strong track record of maximizing operating efficiencies and growth

13

Chart represents a unique investment opportunity to capitalize on the return

of strong growth in the markets it serves